Whats new
Whats new.
Canaccord Genuity - Ticking all the boxes - initial positive read from efti in soft tissue sarcoma; Rated Buy, A$1 Price Target (Analyst: Elyse Shapiro)
May 2nd 2024
For a copy of this research report please contact your Canaccord Genuity advisor